Press Release
Lund, Sweden, October 16 2019
ImmuneBiotech Medical Sweden AB, the probiotic and microbiome company, is pleased to announce the market launch of its first product – GutMagnificTM as a food supplement for gutrelated conditions on the company’s web shop www.GutMagnific.com.
GutMagnificTM is a super-consortium (combination) of five probiotic lactobacillus strains, scientifically designed to address the underlying key causes of IBS and will be sold as a food supplement supported by clinical data. GutMagnificTM is the first product in a new probiotic category ImmuneBiotics™ where products are developed using pharmaceutical precision focused on achieving a healthy balance between the microbiome, the immune system, and the intestinal systembarrier.
“I’m extremely pleased that our more than 15 years of experience in probiotics, immunology, microbiology and research in the gut-brain-axis has matured to a probiotic supplement ready for the market. There are many probiotic products out there, most of these do not have an effect on chronic conditions. To me, customer needs have always been the main motivation and we have designed GutMagnificTM based on input from physicians and customers using similar research methods as in drug development. We are proud of our highly innovative probiotic supplement that can help many people with years of suffering from gut-related conditions.” said Shahram Lavasani, CEO of ImmuneBiotech.